What’s new

AIMM Therapeutics presents new preclinical data at AACR 2020

AIMM Therapeutics Presents Preclinical Data on its Four Oncology Therapies at AACR’s Annual Meeting Session on Antibody Technologies (more…)

Read more

What’s in a NAIMM?

AIMM is changing, so is our identity. We are pleased to present the new corporate identity. By doing so, we want to bring clarity to who we are and what we do. (more…)

Read more